ICAM1 and chronic kidney disease: Pawlak et al. [14] showed that plasma endocan levels were significantly increased in patients with CKD, and independently associated with soluble intercellular adhesion molecule-1 and soluble vascular cell adhesion molecule-1, which affect the prevalence of cardiovascular disease in these patients.